Day: June 24, 2021

CHICAGO, June 24, 2021 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that Aaron Miles, the Company’s Chief Investment Officer, will present at VirtualInvestorConferences.com, the leading investor conference series for publicly-traded companies on Tuesday, June 29. DATE: Tuesday, June 29TIME: 10:00 AM ETLINK TO WATCH: https://bit.ly/34Tj6je This will be a live, interactive online event for individual and institutional investors, as well as advisors and analysts. If attendees are unable to join the event live, an archived webcast will also be made available after the event. To learn more about the event, please visit www.virtualinvestorconferences.com. About Virtual Investor Conferences® Virtual Investor Conferences (VIC) is...

CAMBRIDGE, Mass., June 24, 2021 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc., an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, today announced that it will be added to the Russell 2000® Index at the conclusion of the Russell US Indexes annual reconstitution on June 28, 2021. “Werewolf’s inclusion in the Russell 2000® index marks an important milestone that reflects the continued progress we are making toward advancing our lead therapeutic programs, WTX-124 and WTX-330, into the clinic,” said Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf Therapeutics. “We are pleased to join the Russell Index and look forward to sharing our story with a broader audience of investors.” The...

SUNNYVALE, Calif., June 24, 2021 (GLOBE NEWSWIRE) — eGain (NASDAQ: EGAN), the leading cloud platform for customer engagement automation, today announced that its clients were the leaders in several industry sectors in Newsweek’s Best Customer Service 2021 Survey. Conducted by the respected global research firm, Statista, the 2021 America’s Best Customer Service rankings were identified from the results of an independent survey of more than 25,000 U.S. customers who have either made purchases, used services, or gathered information about products or services in the past three years. Customers evaluated several brands: in total, 160,000 evaluations were collected. The awarded brands each received, on average, close to 100 evaluations from customers. The survey was conducted on retailers and service providers from 160 categories,...

METTAWA, Ill., June 24, 2021 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) today announced that it has entered into a definitive agreement to acquire Navico, a global leader in marine electronics and sensors for $1.05 billion. As a result of this acquisition, Brunswick will add the industry leading brands of Lowrance, Simrad, B&G, and C-MAP to its Advanced Systems Group (ASG), which includes the leading Parts & Accessories (P&A) brands in power management, digital control and monitoring, and networked devices. “The acquisition of Navico and its award-winning brands will immediately accelerate Brunswick’s ACES (Autonomy, Connectivity, Electrification and Shared-Access) strategy, and support our vision to deliver distinctive new products and technology-enabled experiences,” said Dave Foulkes, Brunswick...

In 2020, the Feintool Group made significant progress in sustainable development: The share of renewable energy in the electricity mix was increased by more than 12 percent year-on-year to 30 percent. Since the beginning of 2021, all plants in Germany have also been sourcing 100 percent green electricity. In its new Sustainability Report for 2020 published today, the technology group has documented facts and figures relating to its sustainability strategy. “Climate change requires a transformation in products, production and society. We want to actively drive these change processes with high-performance sheet metal technology for the mobility of tomorrow, with globally attractive jobs and a continuous reduction of our ecological footprint to climate neutrality,” explains Knut Zimmer, CEO of Feintool. “Following our second...

Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.    KEY INFORMATIONName of person dealing (Note 1) Man Group PLC/JerseyCompany dealt in STRONGBRIDGE BIOPHARMA PLCClass of relevant security to which the dealings being disclosed relate (Note 2) $0.01 ordinary sharesDate of dealing 2021-06-232.    INTERESTS AND SHORT POSITIONS (a)    Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)  Long Short  Number   (%) Number   (%)(1) Relevant securities 691,308 1.0228 0.00 0.00(2) Derivatives (other than options) 0.00 0.00 0.00 0.00(3) Options and agreements to purchase/sell 0.00 0.00 0.00 0.00Total 691,308 1.0228 0.00 0.00(b)    Interests...

Lundin Energy AB announces that its wholly owned subsidiary, Lundin Energy Norway AS (together Lundin Energy), has been awarded two exploration licence interests in the 25th licensing round, in Norway. The award comprises two licences in the Southern Barents Sea, consolidating the Company’s position around the Wisting discovery (Lundin Energy 10 percent working interest). Both of the awarded licences will be operated by Equinor with Lundin Energy as partner. The licence interests are detailed below.Licence Blocks Working Interest Area1133 7324/4 20% Barents Sea1134 7323/2,3; 7324/1; 7423/12; 7424/10,11,12; 7425/10 30% Barents SeaFor further information, please contact: Edward WestroppVP Investor RelationsTel: +41 22 595 10 14edward.westropp@lundin-energy.com Robert ErikssonHead of Media CommunicationsTel: +46 701 11 26 15robert.eriksson@lundin-energy.comLundin...

RESEARCH TRIANGLE PARK, N.C., June 24, 2021 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate) for the prevention of platinum-induced ototoxicity in pediatric patients with localized, non-metastatic solid tumors, today announced an amendment to its existing senior debt facility with the Life Sciences Group at Bridge Bank increasing the size of the facility from $18 million to $20 million. The U.S. operating subsidiary of Fennec Pharmaceuticals Inc. entered into a Second Amendment to the 2019 Loan and Security Agreement with Bridge Bank. This amendment provides Fennec with a $20 million debt facility comprised of three term loans. Term Loan A consists of $5.0 million to be funded upon closing....